Medically reviewed by Susan Russell, MDLung cancer prognosis tends to be better for people diagnosed in earlier stages of the ...

Study results show that a portable breath analysis device designed for early detection of non–small cell lung cancer may distinguish between patients with the disease and healthy individuals.

The survival rate depends on the cancer stage, type, and other factors. The five-year survival rate for stage 3 non-small cell lung cancer is 37%. Small cell lung cancer is often more aggressive ...

An increasing number of non-smokers are being diagnosed with lung cancer for a variety of reasons. To better understand this ...

MSK identified a new subtype of small cell lung cancer in young non-smokers, challenging existing treatment paradigms with ...

the most common type of lung cancer. These findings open the ... Genetic Signature May Predict Response to Immunotherapy for Non-Small Cell Lung Cancer Feb. 23, 2024 — A new study identified a ...

The authors concluded that there was evidence for an increased risk for lung cancer due to alcohol and coffee intake, amidst ...

One in 16 Americans will be diagnosed with lung cancer in their lifetime. As the leading cause of cancer deaths in the U.S., ...

This includes targeted therapy for the most common form of the disease, non-small cell lung cancer (NSCLC ... Immunotherapy ...

Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...

Melanie Erwin was stunned when scans revealed she had stage 4 lung cancer, and now wants to smash the misconceptions ...